Latest California Healthline Stories
A lawsuit claims that a private company hired by the state public health department to manage enrollment in an AIDS drug assistance program for low-income patients inadvertently allowed unauthorized access to their medical status.
In a bold move, the state has sued Sutter Health, Northern California’s dominant hospital chain, whose prices have drawn complaints for years. The company says “healthy competition and choice exists across Northern California” for consumers seeking medical care.
In September, the Trump administration announced its plan to end the Deferred Action for Childhood Arrivals program, setting off an ongoing political and legal battle that could doom the dreams of immigrant doctors in training.
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it — or at least salvage its own reputation.
Three participants in unauthorized herpes vaccine research file a lawsuit against scientist’s company, alleging adverse side effects.
California officials should have obtained federal approval before they cut reimbursement rates for dental hygienists who serve frail Californians living in nursing homes and board-and-care facilities, a judge has ruled.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Sarah Kliff of Vox discuss the latest lawsuit challenging the constitutionality of the Affordable Care Act. They also explore how your health care system increasingly depends on the state you live in. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
Orange County Superior Court judge says “media blitzkrieg” jeopardized chances that the nation’s third-largest health insurer could get a fair jury trial if the trial started this week, as planned. The company is being sued by a man who claims it improperly denied him care for a rare immune system disorder.
In a low-tech snafu, information about HIV treatment was visible through the cellophane window on envelopes sent to about 12,000 consumers.
The Seattle jurist finds that Olympus Corp. failed to properly disclose evidence that it knew of concerns about cleaning problems with its redesigned medical scopes years before they hit the market and were linked to dozens of deaths. The company maintains the devices were not defective and intends to appeal.